New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
-
Form SC 13D/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
ReCode Therapeutics Establishes Scientific Advisory Board
-
Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Board of Directors
-
Tessera Therapeutics Appoints Industry Leaders Elliott Sigal & Mary Rozenman to Board of Directors
-
Form SC 13D Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
Adaptimmune Therapeutics (ADAP) Announces $100M Registered Direct Offering of ADSs
-
Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares
-
Form SC 13G/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
Form 4 Adaptimmune Therapeutics For: Mar 27 Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
Adaptimmune Therapeutics (ADAP) Chairman Knowles to Step Down; Successor Named
-
Adaptimmune Announces Succession Plan for Chairman at End of 2016
-
Form SC 13G Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
Adaptimmune Wins Scrip Award for Financing Deal of the Year
-
Adaptimmune Wins Scrip Award for Financing Deal of the Year
